Alliancebernstein L.P. 10x Genomics, Inc. Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

A detailed history of Alliancebernstein L.P. transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 35,848 shares of TXG stock, worth $512,984. This represents 0.0% of its overall portfolio holdings.

Number of Shares

35,848

Previous 42,518 15.69%

Holding current value

$512,984

Previous $826,000 2.06%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$15.71 - $23.49 $104,785 - $156,678	-6,670 Reduced 15.69%	35,848 $809,000
Q2 2024 Aug 14, 2024	BUY	$19.45 - $37.37 $218,306 - $419,440	11,224 Added 35.87%	42,518 $826,000
Q1 2024 May 14, 2024	BUY	$36.08 - $54.3 $23,812 - $35,838	660 Added 2.15%	31,294 $1.17 Million
Q4 2023 Feb 14, 2024	BUY	$34.32 - $57.55 $42,831 - $71,822	1,248 Added 4.25%	30,634 $1.71 Million
Q3 2023 Nov 14, 2023	SELL	$40.86 - $62.98 $36,283 - $55,926	-888 Reduced 2.93%	29,386 $1.21 Million
Q2 2023 Aug 15, 2023	SELL	$50.96 - $58.72 $16,307 - $18,790	-320 Reduced 1.05%	30,274 $1.69 Million
Q1 2023 May 15, 2023	SELL	$35.33 - $55.79 $223,462 - $352,871	-6,325 Reduced 17.13%	30,594 $1.71 Million
Q4 2022 Feb 14, 2023	BUY	$24.4 - $41.3 $3,172 - $5,369	130 Added 0.35%	36,919 $1.35 Million
Q3 2022 Nov 15, 2022	BUY	$28.48 - $52.59 $1,965 - $3,628	69 Added 0.19%	36,789 $1.05 Million
Q2 2022 Aug 15, 2022	BUY	$36.95 - $82.41 $24,534 - $54,720	664 Added 1.84%	36,720 $1.66 Million
Q1 2022 May 13, 2022	SELL	$55.7 - $145.79 $43.5 Million - $114 Million	-780,682 Reduced 95.59%	36,056 $2.74 Million
Q4 2021 Feb 14, 2022	BUY	$135.05 - $182.59 $9.89 Million - $13.4 Million	73,255 Added 9.85%	816,738 $122 Million
Q3 2021 Nov 10, 2021	BUY	$145.58 - $192.14 $13 Million - $17.2 Million	89,390 Added 13.67%	743,483 $108 Million
Q2 2021 Jul 30, 2021	BUY	$134.22 - $202.37 $2.97 Million - $4.47 Million	22,112 Added 3.5%	654,093 $128 Million
Q1 2021 May 06, 2021	SELL	$140.25 - $196.86 $21.1 Million - $29.6 Million	-150,344 Reduced 19.22%	631,981 $114 Million
Q4 2020 Feb 08, 2021	SELL	$126.47 - $163.7 $56.7 Million - $73.4 Million	-448,131 Reduced 36.42%	782,325 $111 Million
Q3 2020 Nov 12, 2020	SELL	$87.44 - $125.0 $26.4 Million - $37.7 Million	-301,794 Reduced 19.7%	1,230,456 $153 Million
Q2 2020 Aug 13, 2020	SELL	$58.39 - $89.31 $2.38 Million - $3.64 Million	-40,760 Reduced 2.59%	1,532,250 $137 Million
Q1 2020 May 14, 2020	BUY	$51.57 - $106.62 $30.7 Million - $63.4 Million	594,693 Added 60.79%	1,573,010 $98 Million
Q4 2019 Feb 18, 2020	BUY	$46.07 - $79.54 $31.3 Million - $54 Million	679,482 Added 227.38%	978,317 $74.6 Million
Q3 2019 Nov 14, 2019	BUY	$49.99 - $62.0 $14.9 Million - $18.5 Million	298,835 New	298,835 $15.1 Million

Others Institutions Holding TXG

# of Institutions

290

Shares Held

94.7M

Call Options Held

263K

Put Options Held

85.1K

View Full List

About 10x Genomics, Inc.

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.36B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

More about TXG

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account

Alliancebernstein L.P. 10x Genomics, Inc. Transaction History